Smoking Cessation Strategies: What Works?

Similar documents
The Interaction of Depression and Smoking following ACS Andrew M. Busch, PhD

Medication Management to Aid in Smoking Cessation. Rachel Constant, Pharm.D. Baptist Health Corbin Pharmacy Resident 3/22/2019

SMOKING CESSATION. Recommendations 5As Approach to Smoking Cessation. Stages of Change Assisting the Smoker. Contributor Dr. Saifuz Sulami.

Tobacco use assessment, brief counseling,, and quit line referral

Smoking Cessation: Where Are We Now? Nancy Rigotti, MD

5. Offer pharmacotherapy to all smokers who are attempting to quit, unless contraindicated.

Pharmacologic Therapy for Tobacco Use & Dependence

Treating Tobacco Use:

Effective Treatments for Tobacco Dependence

Introduction to pharmacotherapy

Tobacco Cessation: Best Practices in Cancer Treatment. Audrey Darville, PhD APRN, CTTS Certified Tobacco Treatment Specialist UKHealthCare

Cessation Medicine Reference Guide Table of Contents

Smoking cessation therapy

My Mask. I keep it all inside. Because I d rather. The pain destroy me. Than everyone else. Anon.

Management of Perinatal Tobacco Use

IMPORTANT POINTS ABOUT MEDICATIONS

PHARMACOTHERAPY OF SMOKING CESSATION

HIV and Aging. Making Tobacco Cessation a Priority in HIV/AIDS Services. Objectives. Tobacco Use Among PLWHA

Tobacco & Nicotine: Addiction and Treatment

Chantix Label Update 2018

Pharmacotherapy for Treating Tobacco Dependence

Tobacco Use Dependence and Approaches to Treatment

How to help your patient quit smoking. Christopher M. Johnson MD, PhD

Tobacco Dependence Screening and Treatment in Behavioral Health Settings. Prescribing

Pharmacotherapy for Tobacco Dependence Treatment

Smoking Cessation: Treating Tobacco Dependence

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE

TRENDS IN TOBACCO UNDERSTAND 5/26/2017 LEARNING OBJECTIVES. Understand the types of tobacco products trending in today s market & associated risks

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO

Varenicline and Other Pharmacotherapies for Tobacco Dependence

Tobacco Cessation: Priority for Health Providers. Acknowledgements. Tobacco Cessation: Secondhand Smoke. Smoke-Free Environment & CA

TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS

TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Addressing Tobacco Use in Iowa

Smoking Cessation Strategies in 2017

Chantix (Varenicline) and Risk of Cardiovascular Events

Slide 1. Slide 2. Slide 3. Reducing Tobacco Use and Nicotine Dependence in Clinical Settings. Goals for Today

TREATMENT INTERVENTIONS

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Population-level Strategies to Prevent and Reduce Tobacco Use Success and Challenge

ADULT BMI ASSESSMENT

Smoking Cessation. MariBeth Kuntz, PA-C Duke Center for Smoking Cessation

After the Last Cigarette

Sample Managed Care Organization Survey Questions to Assess Smoking Prevalence and Available Cessation Benefits

Smoke-free Hospitals. Linda A. Thomas, MS University of Michigan Health System Tobacco Consultation Service

Massachusetts Tobacco Cessation and Prevention Program, MDPH Updated 3/15/2012 Over-the-counter stop-smoking medicines covered: GIC Members

Nicotine Replacement and Smoking Cessation: Update on Best Practices

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

Pharmacologic Therapy for Tobacco Use & Dependence Nicotine Replacement Therapy (NRT) and Bupropion

3. Chantix [package insert]. New York, NY: Pfizer, Inc,; Ramon JM, Morchon S, Baena A, Masuet-Aumatell C. Combining varenicline and nicotine

Best Practices in Tobacco Treatment IDN

See Important Reminder at the end of this policy for important regulatory and legal information.

Updates in the Treatment of Tobacco Use Disorder

NYSMPEP Smoking Cessation Guidance: Key Message 3

Smoking Cessation and the Pharmacist

An Evolving Perspective on Smoking Cessation Therapies

Save a Life in 3 Minutes

4/2/2015. Inpatient Smoking Cessation. Smoking Cessation Documentation Patient's Stage of Behavior Change

Smoking Cessation Services Guidance

See Important Reminder at the end of this policy for important regulatory and legal information.

Helping People Quit Tobacco

TB and Tobacco: Pharmacotherapy for Tobacco. Cessation. Cathy Cook, LCSW, CTTS

The Kentucky Department for Public Health University of Kentucky College of Nursing Local Health Department Tobacco Cessation Survey, 2007

Fast Facts. Morbidity and Mortality (Related to Tobacco Use)

Smoking Cessation: Nurse Interventions and Effective Programs

7 DAY QUIT SMOKING CHALLENGE 7 DAY QUIT SMOKING CHALLENGE 7 DAY QUIT SMOKING PDF YOU CAN QUIT SMOKING. QUIT SMOKING CDC 1 / 5

UPDATE TREATMENT OF TOBACCO USE DISORDERS

The Kentucky Department for Public Health University of Kentucky College of Nursing Local Health Department Tobacco Cessation Survey, 2006

Updates in the Treatment of Tobacco Use Disorder

Al Heuer, PhD, RRT, RPFT Professor & Program Dir. Rutgers School of Health Related Professions

Helping Employees Break the Habit

Month/Year of Review: March 2014 Date of Last Review: April 2012

Motivating Smoking Cessation: Recognizing and Capitalizing on Teachable Moments

HIV & TOBACCO USE PHARMACOLOGIC AND BEHAVIORAL METHODS TO HELP YOUR PATIENTS QUIT

WANTED. Pharmacists to Help Patients Quit Smoking: Best practices and updates in cessation treatment. Robin Corelli, PharmD

Tobacco Basics and Brief Cessation Interventions. Prepared by: Margie Kvern, RN, MN Diane Mee, RN, BN October 2014

Drug Use Evaluation: Smoking Cessation

Tobacco use and dependence: an updated review of treatments

Tobacco treatment for people with serious mental illness (SMI)

Tobacco Cessation The Role of the Dentist/Oral Medicinist

Pharmacotherapy Safety and Efficacy in Adolescent Smoking Cessation

AIDS for CESSATION PHARMACOTHERAPY. METHODS for QUITTING. NONPHARMACOLOGIC METHODS (cont d) NONPHARMACOLOGIC METHODS

St. Joseph s Health PROVIDER BRIEF. Tobacco Dependence Treatment Guidelines Perinatal and Postpartum Women

WHAT IS THE GUIDELINE

Cigarettes and Other Tobacco Products

Save Lives and Money. Help State Employees Quit Tobacco

SECTION 17: NICOTINE REPLACEMENT. Formulary and Prescribing Guidelines

Formulary and Prescribing Guidelines

Brief Intervention for Smoking Cessation. National Training Programme

Faculty Disclosure. Objectives. Lung Cancer in Kentucky: Improving Patient Outcomes 10/28/16. Lung Cancer Burden in Kentucky

Smoking Cessation Counseling Strategies

SMOKING CESSATION WORKSHOP. Dr Mark Palayew December

Over the Road Truck Driver Who Smokes

Background. Abstinence rates associated with varenicline

Treatment of Tobacco Dependence

Pharmacological Treatments for Tobacco Users with Behavioral Health Conditions

Transcription:

Smoking Cessation Strategies: What Works? Andrew M. Busch, Ph.D. Centers For Behavioral and Preventive Medicine The Miriam Hospital Department of Psychiatry and Human Behavior Alpert Medical School of Brown University

Faculty Disclosure Andrew M. Busch has the following disclosures: Consultant: None Stockholder: None Research grants : K23 Career Development Award (K23HL107391, NHLBI)

Smoking Morbidity and Mortality Smoking is a known cause of: multiple cancers heart disease Stroke COPD Smoking is (arguably) the most important modifiable risk factor for CVD Smoking causes 443,000 deaths in the US/year 126,000 due to CVD 50,000 more due to second-hand smoke exposure CDC MMWR 2008; Fiore et al., 2008; Ezzati et al., 2004

Effects of Smoking Cessation Quitting Smoking: before the age of 40 reduces smoking related mortality risk by 90% before the age of 55 adds 6-10 years to lifespan after a heart attack reduces 2 year mortality by 36% after a lung cancer diagnosis greatly reduces recurrence and mortality Critchley JA, Capewell 2003; Jha et al 2013; Wu et al 2011 4

Smoking Statistics National smoking rate 2012: 19.6% RI 17.4% MA 16.4% 69% want to stop smoking completely 52% attempted to quit in past year 5% of attempts are successful 68% attempted without any medication or counseling CDC BRFSS 2012, CDC MMWR 2010, Rafful et al 2013

Smoking Cessation at Medical Visits: The 5As Ask about smoking status at every visit Advise to quit (clear, strong, personalized) Fiore et al., 2008 6

Smoking Cessation at Medical Visits: The 5As Ask about smoking status at every visit Advise to quit (clear, strong, personalized) Ask + Advise alone increase quit rates by 2.5% Fiore et al., 2008 7

Smoking Cessation at Medical Visits: The 5As Ask about smoking status at every visit Advise to quit (clear, strong, personalized) Assess willingness to make a quit attempt Assist in development of a quit plan Arrange for follow-up (1 week is ideal) Fiore et al., 2008 8

Smoking Cessation at Medical Visits: The 5As Ask about smoking status at every visit Advise to quit (clear, strong, personalized) Assess willingness to make a quit attempt Assist in development of a quit plan Arrange for follow-up (1 week is ideal) Depending on setting, these may be referred out Fiore et al., 2008 9

First Line Treatments Behavioral counseling Individual, group, Quit-lines Nicotine Replacement Therapy (NRT) Nicotine Patch (OTC) Nicotine Gum (OTC) Nicotine Lozenge (OTC) Nicotine Inhaler (Rx) Nicotine Spray (Rx) Pill Medication (start 1-2 weeks before cessation) Bupropion SR (Wellbutrin, Zyban) Varenicline (Chantix) Highest quit rates and most side effect concerns Fiore et al., 2008

Combination Treatments Are Most Effective Any medication + counseling Nicotine patch + other NRT Any NRT + Bupropion Fiore et al., 2008

Relapse Even with the best treatments, 65% of your patients that attempt to quit will be smoking again in 6 months 12

Safety Concerns NRT has very few safety concerns Contraindications: Pregnant/nursing, skin allergies (patch), severe reactive airway disease (nasal spray) Common side effects: vivid dreams (patch) Generally safe for CVD patients use with caution within 2 weeks of MI and for those with serious arrhythmias or unstable angina Fiore et al., 2008; Joseph 1996 13

Safety Concerns Bupropion Contraindications: pregnancy, history of seizure or eating disorder, MAO inhibitor in past 14 days Common side effects: insomnia Generally well tolerated in CVD patients Even post-mi patients Fiore et al., 2008; Rigotti et al., 2006 14

Safety Concerns Varenicline Contraindications: pregnancy Common side effects: Nausea, trouble sleeping, abnormal/strange dreams Black box warning for hostility & agitation, depressed mood and suicidal ideation/behavior Small increase in risk of cardiac events in both CVD and non-cvd samples FDA 2011; Fiore et al., 2008; Singh et al 2011 15

Patients who are unmotivated to Quit: 5Rs Discuss with patients: personal Relevance of smoking, Risks of smoking Rewards of quitting Roadblocks to quitting for which the provider suggests possible solutions Repeat at subsequent visits Fiore et al., 2008 16

Resources Clinical guidelines (includes dosing recommendations) Fiore et al 2008: Treating Tobacco Use and Dependence: 2008 Update www.ahrq.gov/professionals/cliniciansproviders/guidelinesrecommendations/tobacco/clinicians/treating_ tobacco_use08.pdf

1-800-QuitNow Resources quitnowri.com (includes local resources) nicotine-anonymous.org BeTobaccoFree.gov Smokefree.gov (also in Spanish) 18